Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The heme oxygenase-1 metalloporphyrin inhibitor stannsoporfin enhances the bactericidal activity of a novel regimen for multidrug-resistant tuberculosis in a murine model

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.01043-23Source: DataRank Database

The heme oxygenase-1 metalloporphyrin inhibitor stannsoporfin enhances the bactericidal activity of a novel regimen for multidrug-resistant tuberculosis in a murine model is a research paper published in Antimicrobial Agents and Chemotherapy (2023). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.75)OA: greenTopics (40)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Pranita Neupane,Styliani Karanika ORCID,Stefanie Krug ORCID,Darla Quijada,Andrew Garcia ORCID

Live enrichment

PubMed:38132181 OpenAlex:https://openalex.org/W4390114540

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: K24AI143447

National Institutes of Health

Grant: 5K24AI143447-02

Mentoring in Immunometabolic Dysregulation in TB and TB/HIV

National Institutes of Health

Grant: 3P30CA006973-53S2

Regional Oncology Research Center

FWCI

0.75

Citation Percentile

0.7%

Citation Trend

2024

2025

2026

greenLicense: https://doi.org/10.1128/ASMCopyrightv2

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10848751/pdf/aac.01043-23.pdf

publisherhttps://journals.asm.org/doi/pdf/10.1128/aac.01043-23

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10848751

journalhttps://doi.org/10.1128/aac.01043-23

Fields of Study

Heme Oxygenase-1 and Carbon MonoxideNeonatal Health and BiochemistryHemoglobin structure and function0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsAntitubercular AgentsDisease Models, AnimalMetalloporphyrinsMycobacterium tuberculosisProtoporphyrinsRecurrenceTuberculosis, Multidrug-ResistantMiceHeme Oxygenase-1

Keywords

Multiple drug resistanceHeme oxygenaseRegimenHemeTuberculosisChemistryMicrobiologyPharmacologyAntibioticsMedicineBiologyBiochemistryInternal medicineEnzymeMiceDisease Models, AnimalMetalloporphyrinsRecurrenceTuberculosis, Multidrug-ResistantAntitubercular AgentsAnimalsProtoporphyrinsMycobacterium tuberculosisArticleHeme Oxygenase-1

Sustainable Development Goals

SDG 0: Good health and well-being